GlassScriptPhysician profile
Marilyn C Horvit
NPI 1447762638
$1,584.21
in general payments reported to CMS, 2019-2025
13 companies · $585 in 2025
The $585 reported for 2025 was more than what 77% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $93.09 · 2023: $455 · 2024: $451 · 2025: $585.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,491.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,491.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $386.32 | 2024-2025 | Triclip, Thoratec Heartmate 3 Lvas Implant Kit, Amplatzer Amulet |
| Janssen Pharmaceuticals, INC | $339.29 | 2023-2024 | Xarelto |
| Amgen INC. | $260.10 | 2023-2025 | Repatha, Repatha |
| Edwards Lifesciences Corporation | $180.92 | 2022-2025 | Sapien 3 Ultra Resilia |
| Boston Scientific Corporation | $138.92 | 2023 | Watchman Flx |
| Novartis Pharmaceuticals Corporation | $80.17 | 2024-2025 | |
| Pfizer INC. | $56.06 | 2024-2025 | |
| Cvrx, INC. | $31.39 | 2025 | Barostim Neo System |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $30.60 | 2025 | Lifevest |
| Esperion Therapeutics, INC. | $23.95 | 2024 | Nexletol |
| Lexicon Pharmaceuticals, INC. | $22.93 | 2024 | |
| Impulse Dynamics (USA) INC. | $17.71 | 2025 | Optimizer |
| Heartflow, INC. | $15.85 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marilyn Horvit listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.